ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017
Correction: Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.
No numbers read from the abstract.
1 paper cites it
this papercites it